ALK Cancer Research

Dr. Jessica Lin describes the best sequence for #ALK & #ROS1 inhibitors at #NACLC22. She says ALK and ROS1 fusion-positive lung cancers represent disease subsets in which we have highly-effective targeted therapies available.

For the latest updates on #ALKPositive #Research follow @ALK_Research

For the latest updates on #ALKPositive #Research follow @ALK_Research #ALKResearch

For the latest updates on #ALKPositive #Research follow @ALK_Research

@ALKpositiveINT @ALKLungCancer @AlkPositiveBE @AlkRos1France @robot_hands @justamammaFC @Janclarkgirls @kitty_is_odd @Yvonne_Diaz_ It's #WorldALKLungCancer day. 15 yrs ago today, Dr Mano of 🇯🇵 discovered #ALKPositive #lungcancer & changed the life expectancy of 💯s of thousands of patients across the globe diagnosed at advanced stage, usually aged 50 or younger & without comorbidities. ありがとうございます

It's #WorldALKLungCancer day. 15 yrs ago today, Dr Mano of Japan discovered #ALKPositive #lungcancer & changed the life expectancy of 💯s of thousands of lung cancer patients. We honor Dr Mano & all research since by funding research. Why not help today? alkinternational.org/fundraising

Day 2: ALK POSITIVE SUMMIT 2022 And...It's a wrap. Video Recordings of the 2022 ALK POSITIVE SUMMIT to follow in due course. Follow @ALK_Research to stay up to date with the latest ALK Positive Research. #StrongerTogether2022 #ALKPositive #ALKResearch

Up next: HOPE with David P Carbone, MD, PhD, Professor of internal medicine at @OhioState ; Co-lead of Translational Therapeutics Program at the @OSUCCC_James & Barbara J. Bonner Chair in Lung Cancer Research #StrongerTogether2022 #ALKPositive #ALKResearch

Day 2: ALK POSITIVE SUMMIT 2022 Starting the day with Drs Lam @vincentlamMD, Creelan, Schenk @SchenkLab, Gagdeel presenting the potential future treatments being explored not yet in trials - why to be excited & hopeful #StrongerTogether2022 #ALKPositive #ALKResearch

Welcome to Day 2 of the ALK POSITIVE SUMMIT 2022! 1st Hybrid Summit! We start with a warm welcome from Nancee Pronsati, ALK Summit 2022 Chair & @ALKadvocate, CEO, ALK Positive, Inc. #StrongerTogether2022 #ALKPositive #ALKResearch alkpositive.org/alk-summit-2022

Day 1: ALK POSITIVE SUMMIT 2022 Closing a great day with presentations on the Research funded by @ALKLungCancer, updates on @LUNGevity & @GO2Foundation partnership research initiatives & International #ALKResearch. Follow @ALK_Research to stay up to date. #StrongerTogether2022

For the latest updates on #ALKPositive #Research follow @ALK_Research

Day 1: ALK POSITIVE SUMMIT 2022 Coming up next: Updates on the partnership between the Lung Cancer Research Foundation @lcrf_org & ALK Positive @ALKLungCancer with Sam Rogers & Colleen Conner Ziegler #StrongerTogether2022 #ALKPositive #ALKResearch alkpositive.org/alk-summit-2022

Day 1: ALK POSITIVE SUMMIT 2022 About to start: Drs Gadgeel, Qin @AngelQinMD and Merajver @sofiamerajver on the University of Michigan’s Personalized Treatments Project @UMRogelCancer @UMich @umichmedicine #StrongerTogether2022 #ALKPositive #ALKResearch alkpositive.org/alk-summit-2022

For the latest updates on #ALKPositive #ALKResearch follow @ALK_Research

Day 1: ALK POSITIVE SUMMIT 2022 Up next, a Discussion and Q&A with Dr. Jessica Lin @JessicaJLinMD & members of the ALK Positive @ALKLungCancer medical committee on treatments for ALK Patients that are Not Current Standards of Care #StrongerTogether2022 #ALKPositive #ALKResearch

Day 1: ALK POSITIVE SUMMIT 2022 Drs Camidge, Gadgeel, Treem, Daly, Randhawa @randhawa_sk, Aisner are presenting the current standards of care & treatment philosophies for #ALKPositive #Cancer & the benefits of a multi-disciplinary team. #ALKResearch @CUCancerCenter

Day 1: ALK POSITIVE SUMMIT 2022 Keynote Speech by Dr. Ross Camidge starting - HOPE and ALK positive lung cancer #StrongerTogether2022 #ALKPositive #ALKResearch alkpositive.org/alk-summit-2022

Welcome to Day 1 of the ALK POSITIVE SUMMIT 2022! 1st Hybrid Summit! We start with a warm welcome from Nancee Pronsati, ALK Summit 2022 Chair & @ALKadvocate, CEO, ALK Positive, Inc. #StrongerTogether2022 #ALKPositive #ALKResearch alkpositive.org/alk-summit-2022

For the latest updates on #ALKPositive #Research follow @ALK_Research

Congrats to Dr. Uwe Rix for his Dept. of Defense @CDMRP Lung Cancer Research Program grant to advance his work, "Multipronged Co-Targeting of ALK/ROS1 & Compensatory Focal Adhesion Kinases in Lung Cancer as a Pre-Emptive Strike to Prevent Development of Drug Resistance."